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ABSTRACT 
Liver transplantation is the most effective treatment for patients with end-stage liver disease. 
While many factors are associated with posttransplant graft failure, it has been suspected that 
liver transplant waiting time is negatively associated with posttransplant survival. Due to the 
suspicion, efforts have been made to reduce wait time for patients. There were some studies 
investigating this relationship recently. However, these studies were performed either with 
restricted samples or using data from a single center, and the results were inconclusive. For 
example, a study showed that after the Model for End-Stage Liver Disease (MELD) era, a longer 
waiting time predicts longer posttransplant survival for adult patients with hepatocellular 
carcinoma, whereas another study found no significant relationship between waiting time and 
posttransplant survival.  
In this study, we quantified the time-varying association (time-varying odds ratio) 
between liver transplant waiting time and posttransplant mortality in the presence of 
retransplantation as a competing risk. We also applied two different methods to estimate the 
cumulative incidence of posttransplant mortality. In the first method, the univariate cumulative 
incidence function method, we assume independence between the liver transplant waiting time 
and posttransplant survival. The second method, the bivariate cumulative incidence function 
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method, takes into account the association between transplant waiting time and posttransplant 
survival. Our analytic dataset was extracted from the United Network for Organ Sharing (UNOS) 
Standard Transplant Analysis and Research (STAR) database. The subjects in our study included 
1,265 transplant candidates who were first on the liver transplant waiting list from 2002 to 2012 
and were 1-11 years old. Our analysis showed that liver transplant waiting time is positively 
associated with posttransplant survival. Further investigation is needed to understand whether 
this finding was because of survivor bias; that is, those who were able to wait longer were 
healthier. Our analysis also indicated that retransplantation has a weak association with liver 
transplant waiting time. 
 
PUBLIC HEALTH SIGNIFICANCE: We applied two different methods to pediatric liver 
transplant data in estimating cumulative incidence of posttransplant mortality. The findings will 
be the first step to help the liver transplant community understand the impact of liver transplant 
waiting time on posttransplant survival, and will help researchers further identify indicators of 
liver transplantation for reducing posttransplant mortality thus have a significant impact on 
future public health research. 
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1.0  INTRODUCTION 
Liver transplantation (LT) is the most effective treatment for patients with end-stage liver 
disease. Currently, the 5-year survival rate for pediatric liver transplant recipients is greater than 
80% in the United States [1]. However, the number of patients on the LT waiting list exceeds the 
number of available grafts. For the period from 2012 to 2014, among 1,589 pediatric recipients, 
36.1% of recipients waited less than 31 days and 14.7% waited 31 to 60 days [1]. Patients who 
qualify for liver transplantation are stratified according to the severity of their illness in order to 
identify more urgent need of liver transplantation. For example, the severity of chronic liver 
disease for patients younger than 12 years of age is measured according to the Pediatric End-
Stage Liver Disease (PELD) scoring system. A higher PELD score indicates a more critical 
medical condition. Under the “sickest children first” allocation policy, pediatric patients younger 
than 12 years of age receive priority according to their PELD scores to reduces 
pretransplantation mortality without reducing posttransplantation survival [2].  
The recovery following liver transplantation is a complex process during which patients 
might experience a series of complications, including rejection and possible infection. As a result 
of these complications, some patients require a second or even third LT. From 2012 to 2014, 
8.8% of pediatric recipients required retransplantation [1]. Furthermore, the timing of liver 
transplantation is critical to minimizing the risk of patients dying on the waiting list in order to 
ensure that the children are in optimal condition to survive transplantation [3]. Efforts have been 
2 
made to reduce the time on the waiting list [4]. There is limited research on the association 
between the time on the LT waiting list and LT survival. A single-center study for adult patients 
with hepatocellular carcinoma (HCC) has shown that waiting time has no relation with 
posttransplant survival [5]. In contrast, another study for adult patients with HCC in a national 
transplant registry has demonstrated that a longer waiting time for HCC patients predicts longer 
posttransplant survival, while a longer waiting time for non-HCC patients predicts shorter 
posttransplant survival [6]. The association between the LT waiting time and posttransplant 
survival remains inconclusive.  
To study the association between the LT waiting time and the posttransplant survival, 
retransplantation has to be taken into account because retransplantation prevents or delays the 
occurrence of posttransplant mortality; this is referred to as a competing risk in survival analysis. 
In addition, because that liver transplantation and posttransplant graft failure are two successive 
events, the posttransplant graft failure time is observable only when the LT waiting time is first 
observed; this is referred to as dependent censoring in survival analysis. These two issues must 
be accounted for when we evaluate the association between the LT waiting time and 
posttransplant graft failure. Our study aims to address these two issues of estimating the 
cumulative probabilities of posttransplant graft failure and examining the time-varying 
association between the liver transplant waiting time and posttransplant mortality in the presence 
of retransplantation competing risk. 
One way to estimate the cumulative probabilities of the cause-specific failure is to use the 
univariate cumulative incidence function (CIF) model [7]. The drawbacks of using this model are 
that it ignores the impact of LT waiting time on the posttransplant mortality and that the 
estimation is restricted to LT recipients.  
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A number of studies were done on the time-to-event data for successive events with 
censoring by the first event, and a number of estimators were proposed [8-13]. In addition, 
bivariate time-to-event data with competing risks censoring were studied and several estimators 
were proposed [14-16]. However, none of these methods is appropriate for the LT data being 
analyzed in this study. Recently, a bivariate cumulative incidence function model was proposed 
for data with two successive event times to estimate the cumulative probabilities of the cause-
specific failure in the subsequent event, in which there exists dependent censoring between the 
two events and the second event time is subject to competing risks [17]. This model also 
provided estimation of the cause-specific odds ratio that can be used to describe the association 
between the two event times. We adopted the method of the bivariate CIF model to investigate 
the association between the LT waiting time and the posttransplant graft failure time. 
To explore the impact of the LT waiting time on posttransplant graft failure, the 
following assumptions were made: 1) Patient death or retransplantation, whichever comes first, 
is defined as a posttransplant graft failure. Each LT recipient could fail from only one of these 
two causes. 2) The LT waiting time had right independent censoring only, and no other 
competing event could occur. 3) The posttransplant graft failure time was subject to censoring 
related to the LT waiting time and it was also subject to independent right censoring.  
The rest of the thesis is organized as follows. In Section 2, we describe the structure of 
the data used in the study, the univariate CIF model, and the bivariate CIF model. We also detail 
the nonparametric estimation of the bivariate CIF, the conditional CIF, and the cause-specific 
odds ratio. In Section 3, we present the results of applying the univariate CIF model and the 
bivariate CIF model to the LT data. We conclude the study with a discussion in Section 4.  
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2.0  METHODS 
2.1 DATASET 
The data used in this study is adopted from the United Network for Organ Sharing (UNOS) 
Standard Transplant Analysis and Research (STAR) data file for patients on the liver transplant 
waiting list. The analytic dataset consists of 1,289 pediatric liver transplant candidates whose age 
at the time of listing was between 1 and 11 years old and whose primary diagnoses were not 
cancers or acute liver disease. For the purpose of our study, we further removed 24 transplant 
recipients because they did not have any posttransplant information. The final dataset includes 
1,265 liver transplant candidates. Variables of interest include PELD score at the time of listing, 
days from listing to transplant, transplant status (transplant or censored), days from transplant to 
graft failure, and posttransplant status (posttransplant death, retransplantation, or censored). 
Two types of time-to-event variables are considered in this study. The first time-to-event 
variable is the LT waiting time and the second one is the posttransplant graft failure time. The 
first time-to-event variable is censored if a transplant candidate had not received a transplant by 
the study cutoff date or was removed from the waiting list for reasons other than transplant (e.g., 
no longer eligible to be a candidate because the patient is too sick or too healthy). The second 
time-to-event variable includes two types of failure: posttransplant patient mortality and 
retransplantation. The posttransplant patient mortality is treated as the event of interest and 
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retransplantation is considered as a competing risk. Transplant recipients are censored if they 
were alive and not retransplanted at the cutoff date for this study. 
2.2 UNIVARATE CUMULATIVE INCIDENCE FUNCTION MODEL 
We assume that each subject may experience two consecutive events. Those who do not 
experience the first event will not have a chance to experience the second event. Those who 
experience the first event may fail from one of the two causes for the second event. The 
univariate CIF model [17] has been developed to estimate cumulative incidence of the second 
event in presence of competing causes and is subject to the assumption of the independence of 
the two successive events. We ignore the first time-to-event and apply the model to data 
including only subjects who had experienced the first event.  
Suppose there are n subjects at the beginning of the study. Among them, m (≤ n) subjects 
experience the first event, and each of the m subjects is subject to two failure types (l = 1, 2) in 
the subsequent event. Let T denote the potential gap time between these two successive events 
and C denote the time of the independent right censoring (i.e., T is independently censored by C). 
We observe (Y, η) for each subject, where Y = min (T, C), η = l·I(Y ≤ C). The data consist of m 
independent and identically distributed copies of (Y, η), denoted as {(Yi, ηi), i = 1, …, m.} 
The univariate CIF is defined by  
 
6 
where ε is a cause indicator and l = 1, 2 is corresponding to the two competing causes in the 
subsequent event; S(t) = P(T > t)  is the all-cause survival distribution of T; and λl(t) is the cause-
specific hazard function. Note that λl (t) is defined by  
 
The univariate CIF Fl(t) can be estimated by using the m observed pairs (Yi, ηi) with the 
empirical form [18] 
                    (2.2.1) 
where l = 1, 2 is corresponding to the two competing causes;  is the Kaplan-Meier 
estimator of the all-cause survival distribution of T evaluated at time just before u;  is 
calculated from {(Yi, ηi), i = 1, …, m} by treating any one of the two competing causes as the 
event of interests, 
 
2.3 BIVARIATE CUMULATIVE INCIDENCE FUNCTION MODEL 
The univariate CIF model is useful only when the assumption of independence of the two 
successive time-to-event data holds. If the two events are indeed correlated, ignoring the 
dependence between these two consecutive times may lead to a biased estimation of the 
cumulative incidence of the cause specific failure in the subsequent event. The bivariate CIF 
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model [17] has been developed to address this issue with no assumptions about the independence 
of two successive time-to-events. The model provides a nonparametric analysis about association 
between the two successive times based on the bivariate cumulative incidences and the 
conditional cumulative incidences, accounting for the dependence of the two successive times. 
We consider that n subjects may experience two successive events and each of them is 
subject to two failure types (l = 1, 2) in the subsequent event. Let X denote the potential first gap 
time and T denote the potential second gap time. Let C denote the time of the independent right 
censoring. Event times X and T are independently censored by C. Note that T is censored by (C - 
X)I(X < C) because T is observable only when X is observed. We observe (Y1, Y2, η1, η2) for each 
subject, where Y1 = min(X, C), Y2 = min{(X + T), C}, η1 = I(X ≤ C),  and η2 = l ·I(X + T ≤ C). The 
data consist of n independent and identically distributed copies of (Y1, Y2, η1, η2), denoted as 
{(Y1i, Y2i, η1i, η2i), i = 1, … , n}.  The pair (Y1i, η1i) is the time to the first event and event status, 
and the pair (Y2i, η2i) is the time to the subsequent event and its status. 
The bivariate CIF is defined by 
 
where ε a is cause indicator and l = 1, 2 is corresponding to the two competing causes in the 
subsequent event, S(x, t) = P(X > x, T > t)  is the bivariate all causes survival distribution of X 
and T, and λl(x, t) is the bivariate cause-specific hazard function. λl(x, t) is defined by  
 
Fl(x, t) is estimated directly by using the observed times and its status {(Y1i, Y2i, η1i, η2i), i 
= 1, …, n}. 
8 
                                                                (2.3.1) 
where l = 1, 2 is corresponding to the two competing causes,  is the Kaplan-Meier 
estimator of the survival distribution G(c) = P(C > c) of the independent censoring time C 
evaluated at just before time Y2i, and  is calculated from {(Y2i, η2i), i = 1, …, n} by treating 
censoring as an event and any one of two competing causes as censoring, 
 
Another approach to estimate Fl(x, t), which is the equivalent to the estimator defined in 
Equation (2.3.1), is by means of the estimation of bivariate cumulative cause-specific hazard 
function and the bivariate all-cause survival distribution of time X and T. For details, refer to 
Chen’s PhD dissertation [17]. 
To study the distribution of T while accounting for the dependence of X and T, the 
conditional CIF is defined by 
 
where ε is a cause indicator and l = 1, 2 is corresponding to the two competing causes, FX( x ) = 
P( X ≤ x ) is the marginal distribution of X, FX( x ) = 1- SX( x ) and SX( x ) is the survival 
distribution of X. Fl (t|x) is estimated by  
                                  (2.3.2) 
9 
where l = 1, 2 is corresponding to the two competing causes,  is calculated from {(Y1i, η1i), 
i = 1, …, n} by means of the Kaplan-Meier estimator  of the survival distribution of X, 
                                (2.3.3) 
 quantifies the cumulative risk of the occurrence for a specific type of event, given 
the occurrence of the previous event by a certain time [17]. When X and T are independent of 
each other, the conditional CIF estimator  defined in Equation (2.3.2) agrees with the 
univariate CIF estimator  defined in Equation (2.2.1) 
To study cause-specific association between X and T based on the conditional CIF Fl(t|x), 
the cause-specific odds ratio, which is a time-dependent association measure, is defined as 
follows.  
               , 
where ε is a cause indicator and l =1, 2 is corresponding to the two competing causes in the 
subsequent event, and M is a fixed constant that can be chosen as appropriate. 
Φl (x, t |M ) is the ratio of the odds for having a cause l successive event by time t 
between those who have early occurrence of the first event and those who develop the first event 
later [17]. Φl (x, t |M ) = 1 indicates that for cause l , T is independent with X. Φl (x, t |M ) > 1 
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indicates that for cause l , T is positively associated with X. Φl (x, t |M ) < 1 indicates that for 
cause l , T is negatively associated with X.  
 Φl (x, t |M )  is estimated by  
             (2.3.4) 
                     (2.3.5) 
where l =1, 2 is corresponding to the two competing causes,  and  are from 
Equation (2.3.1),  is from Equation (2.3.2),  and  are from Equation (2.3.3). 
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3.0  RESULTS 
3.1 WAITING TIME AMONG LIVER TRANSPLANT CANDIDATES 
Table 1 summarizes the PELD score at the time of listing among the LT candidates. A total of 
1,265 LT candidates were included in the study, in which 911 (72%) were LT recipients. Of the 
1,265 candidates, 453 (35.81%) candidates had listing PELD scores less than 0, 408 (32.25%) 
had listing PELD scores between 0 and 10, 228 (18.02%) had listing PELD scores between 11 
and 20, 113 (8.83%) had listing PELD scores between 21 and 30, and the rest of the candidates, 
63 (4.98%), had listing PELD scores greater than 30. For the subsequent analyses, we divided 
the candidates into 4 groups according to their listing PELD score (<0, 0-10, 11-20, and >20). 
We collapsed the candidates whose listing PELD scores were greater than 20 into one group to 
increase the sample size. 
 
Table 1. PELD score at the time of listing among liver transplant candidates  
 All Alive and waiting LT^ LT^ Recipient 
 (n=1,265)  (n=354) (n=911)  
         PELD*         n (%)    
             < 0 453 (35.81) 145 (40.96) 308 (33.81) 
             0 - 10 408 (32.25)  97 (27.40) 311 (34.14) 
            11 - 20 228 (18.02) 64 (18.08) 164 (18.00) 
            21 - 30         113 (8.93)            32 (9.04) 81 (8.89) 
            > 30           63 (4.98)            16 (4.52) 47 (5.16) 
* Pediatric end-stage liver disease model 
^ Liver transplantation 
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The LT waiting time and posttransplant graft failure time are two consecutive event times 
in the study. We examined the distribution of the LT waiting time and the results are summarized 
as follows. Figure 1 illustrates the Kaplan-Meier estimate (with 95% CI) of rate of LT. Figures 2 
and 3 depict the rates by the category of the listing PELD scores. The median waiting time to LT 
was 113 days (95% CI: 100-136 days). The results showed that candidates with listing PELD 
score greater than 20 (the sickest patients) had the shortest median waiting time of 11 days (95% 
CI: 8-18 days) while candidates with listing PELD scores less than 0 (the healthiest patients) had 
the longest median waiting time of 176 days (95% CI: 147-222 days). The median waiting time 
among candidates with listing PELD scores 0-10 was 128 days (95% CI: 106-166 days), and the 
median waiting time among candidates with listing PELD scores 11-20 was 90 days (95% CI: 69 
to 133).  
 
Figure 1. Kaplan-Meier curve of liver transplant rate with 95% confidence interval 
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Figure 2. Kaplan-Meier curve of liver transplant rate by listing PELD score among candidates waiting 0 to 3000 
days 
 
 
Figure 3. Kaplan-Meier curve of liver transplant rate by listing PELD score among candidates waiting 0 to 500 days 
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3.2 WAITING TIME AMONG LIVER TRANSPLANT RECIPIENTS 
Table 2 summarizes the waiting time of all LT recipients in accordance with their PELD scores 
at the time of listing. Of the 911 LT recipients, 81 (8.9%) received retransplantation and 69 
(7.6%) died without retransplantation. Among 911 LT recipients, 308 (33.8%) had listing PELD 
scores less than 0, 311 (34.1%) had listing PELD scores between 0 and 10, 164 (18.0%) had 
listing PELD scores between 11 and 20, 81 (8.9%) had listing PELD scores between 21 and 30, 
and 47 (5.2%) had listing PELD scores greater than 30. The median waiting time among all 
recipients was 62 days. 
 
Table 2. PELD score at the time of listing and waiting time among liver transplant recipients 
 All Alive Retransplantation Death 
 (n=911) (n=761) (n=81) (n=69) 
PELD*       n (%)     
            < 0 308 (33.81) 268 (35.22) 27 (33.33) 13 (18.84) 
            0 - 10 311 (34.14) 253 (33.25) 28 (34.57) 30 (43.38) 
            11 - 20 164 (18.00) 137 (18.00) 15 (18.52) 12 (17.39) 
            21 - 30 81 (8.89) 69 (9.07) 7 (8.64) 5 (7.25) 
            > 30 47 (5.16) 34 (4.47) 4 (4.94)  9 (13.04) 
Waiting time    (days)  
            Median (IQR) 62 (18 - 175) 66 (19 - 183) 49 (17 - 165) 42 (8 - 107) 
            Mean ± SD  144 ± 230 148 ± 228 147 ± 285 98 ± 165 
            Range  1 - 2029 1 - 1085 1 - 2029 1 - 1068 
*PELD = Pediatric end-stage liver disease model 
 
 
 
 
 
 
15 
Figure 4 illustrates the Kaplan-Meier estimates of posttransplant survival rate among LT 
recipients. The overall 5-year posttransplant survival rate of LT recipients was 84.05% (95% CI: 
81.97% to 86.38%). 
 
Figure 4. Kaplan-Meier curve of posttransplant survival rate with 95% confidence interval 
 
 
Figure 5 and 6 illustrate the Kaplan-Meier estimates of posttransplant survival rate among 
LT recipients stratified by their listing PELD scores. The survival rates within 1 month after LT 
were similar across the four PELD groups. The recipients who had listing PELD scores less than 
0 and those who had listing PELD scores 11-20 had similar 1-year survival rates. The 5-year 
survival rates for the recipients who had listing PELD scores less than 0, 0-10, 11-20, and greater 
than 20 were 87.5% (95% CI: 83.1%-90.8%), 82.7% (95% CI: 77.7%-86.7%), 83.2% (95% CI: 
75.9%-88.4%), and 80.0% (95% CI: 71.8%-86.3%), respectively.  
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Figure 5. Kaplan-Meier curve of posttransplant survival rate by listing PELD score among recipients surviving 0 to 
4000 days posttransplantation 
 
 
 
Figure 6. Kaplan-Meier curve of posttransplant survival rate by listing PELD score among recipients surviving 0 to 
500 days posttransplantation 
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3.3 ESTIMATED CUMULATIVE INCIDENCE OF POSTTRANSPLANT 
MORTALITY USING THE UNIVARIATE MODEL 
While ignoring the dependency between the transplant waiting time and posttransplant survival 
we used Equation (2.2.1) to estimate the cumulative incidences of posttransplant mortality. Let l 
indicate the type of graft failure, where l = 1 indicates posttransplant mortality and l = 2 indicates 
retransplantation. Let random variable T denote the graft failure time and m be the total number 
of LT recipients. In our study, m = 911. We used the R function cuminc from the library cmprsk 
to estimate the cumulative incidence functions.  
Table 3 summarizes the estimated cumulative incidences of posttransplant mortality and 
retransplantation. We selected 0.5, 1.0, 1.5, 2.0, 2.5, 3, and 5 years after LT for demonstration. 
The results showed that posttransplant mortality rates were lower than the retransplantation rates 
at all selected time points. We further estimated these rates stratified by the listing PELD scores. 
Table 4 shows that recipients with listing PELD score less than 0 had the lowest mortality rate, 
while recipients with listing PELD score greater than 20 had the highest mortality rate. Mortality 
rates for the recipients with listing PELD scores 0-10 were higher than those with listing PELD 
score 10-20. Retransplantation rates among the 4 PELD groups were similar. 
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Table 3. Cumulative incidences of posttransplant mortality and retransplantation among 911 liver transplant 
recipients 
Graft failure time (years) 
Event 0.5 1.0 1.5 2.0 2.5 3 5 
      Posttransplant death 0.0407 0.0486 0.0508 0.0554 0.0589 0.0636 0.0724 
      Retransplantation 0.0473 0.0529 0.0552 0.0608 0.0655 0.0702 0.0871 
 
 
 
Table 4. Cumulative incidences of posttransplant mortality and retransplantation by listing PELD score 
among 911 liver transplant recipients 
 Posttransplant death time (years) 
PELD* 0.5 1.0 1.5 2.0 2.5 3 5 
< 0 0.0195 0.0228 0.0228 0.0228 0.0297 0.0332 0.0332 
0 to 10 0.0581 0.0614 0.0614 0.0647 0.0618 0.0749 0.0749 
11 to 20 0.0305 0.0428 0.0428 0.0553 0.0553 0.0619 0.0619 
> 20 0.0532 0.0875 0.1040 0.1123 0.1123 0.1123 0.1123 
 Retransplantation time (years) 
PELD* 0.5 1.0 1.5 2.0 2.5 3 5 
< 0 0.0552 0.0618 0.0651 0.0651 0.0685 0.0720 0.0825 
0 to 10 0.0452 0.0518 0.0551 0.0618 0.0651 0.0651 0.0651 
11 to 20 0.0366 0.0428 0.0428 0.0491 0.0491 0.0556 0.0621 
> 20 0.0471 0.0471 0.0471 0.0638 0.0638 0.0638 0.0638 
*PELD = Pediatric end-stage liver disease model 
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Figure 7 and 8 summarize these estimated cumulative incidences graphically. The 
cumulative probabilities of posttransplant death were lower than the probabilities of 
retransplantation within 10 years. When the recipients survived beyond 10 years, the cumulative 
probabilities of death became higher than those of retransplantation. Recipients with listing 
PELD scores less than 0 had the lowest mortality rates over time. Recipients with listing PELD 
scores greater than 20 had the highest mortality rates within 10 years of LT. Mortality rates 
among recipients with listing PELD scores 0-10 became the highest after posttransplant 10 years. 
Recipients with listing PELD scores 0-10 had higher mortality rates overtime compared with 
those with listing PELD scores 11-20. The retransplantation rates across the 4 PELD groups 
were similar. 
 
Figure 7. Cumulative incidences of posttransplant mortality and retransplantation (the left panel is for failure time 0 
to 4000 days and the right panel is for failure time 0 to 200 days) 
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Figure 8. Cumulative incidences of posttransplant mortality and retransplantation by listing PELD (the left panel is 
for failure time 0 to 4000 days and the right panel is for failure time 0 to 200 days) 
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3.4 ESTIMATED CUMULATIVE INCIDENCE OF POSTTRANSPLANT 
MORTALITY USING THE BIVARIATE MODEL 
To account for the dependency between the waiting time and posttransplant mortality, we used 
Equations (2.3.1), (2.3.2), (2.3.3), (2.3.4), and (2.3.5) to estimate the cumulative incidence of 
posttransplant mortality and the odds of posttransplant death for recipients who had different LT 
waiting time. Let random variable X indicate LT waiting time and n be the number of LT 
candidates. In our study, n = 1,265 and M was set to be 305 days to include the longest graft 
failure time in the dataset. The bivariate cumulative incidence of transplant waiting time and 
posttransplant mortality, and the conditional cumulative incidence of posttransplant mortality for 
given transplant waiting time were both estimated using the R function Estimator_LinCFKcondi 
[17] (personal contact).   
Table 5 summarizes the estimated cumulative incidences of posttransplant mortality and 
retransplantation conditional the LT waiting time, evaluated at the waiting time of 3, 30, 60, and 
90 days and posttransplant death time of 0.5, 1.0, 1.5, 2.0, 2.5, 3 and 5 years. The standard errors 
were estimated based on 1,000 bootstrap samples. The R code for bootstrap resamples is 
provided in the Appendix. For the LT waiting times of 3 and 30 days and any fixed graft failure 
time, the cumulative probabilities of posttransplant death were higher than the cumulative 
probabilities of retransplantation. For the LT waiting time of 60 and 90 days and most of graft 
failure times, the cumulative probabilities of death were also higher than the probabilities of 
retransplantation. The estimated conditional cumulative incidence of posttransplant mortality 
using the bivariate CIF model did not agree with that using the univariate CIF model. It is worth 
noting that we employed two different approaches [17] to estimate the CIFs and both approaches 
gave similar results.  
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Table 6 summarizes the estimated cumulative incidences stratified by the PELD scores at 
the time of listing, evaluated at the LT waiting times of 3, 30, 60, and 90 days and posttransplant 
death time of 5 years. For any fixed waiting time, the LT recipients with listing PELD scores less 
than 0 had the lowest cumulative probabilities of posttransplant death, while the probabilities of 
posttransplant death for the recipients with listing PELD scores 11-20 and that for the recipients 
with listing PELD score greater than 20 were similar.  
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Table 5. Cumulative incidences of posttransplant mortality and retransplantation accounted for waiting time (standard errors are in the parentheses) 
 Posttransplant death (years) 
 0.5 1.0 1.5 2.0 2.5 3 5 
LT^ waiting time (days)        
3 0.0851 (0.0320) 0.1129 (0.0394) 0.1153 (0.0377) 0.1278 (0.0414) 0.1332 (0.0404) 0.1519 (0.0446) 0.1872 (0.0506) 
30 0.0587 (0.0142) 0.0704 (0.0149) 0.0715 (0.0149) 0.0743 (0.0145) 0.0900 (0.0170) 0.1050 (0.0184) 0.1118 (0.0184) 
60 0.0487 (0.0039) 0.0582 (0.0123) 0.0650 (0.0125) 0.0681 (0.0131) 0.0726 (0.0136) 0.0824 (0.0144) 0.0902 (0.0153) 
90 0.0439 (0.0097) 0.0557 (0.0115) 0.0574 (0.0114) 0.0687 (0.0143) 0.0732 (0.0135) 0.0797 (0.0134) 0.0868 (0.0135) 
 Retransplantation (years) 
 0.5 1.0 1.5 2.0 2.5 3 5 LT^ waiting time (days)        
3 0.0453 (0.0215) 0.0543 (0.0263) 0.0552 (0.0271) 0.0565 (0.0278) 0.0583 (0.0280) 0.0571 (0.0280) 0.0800 (0.0347) 
30 0.0431 (0.0121) 0.0332 (0.0501) 0.0507 (0.0129) 0.0520 (0.0125) 0.0653 (0.0149) 0.0797 (0.0170) 0.0934 (0.0179) 
60 0.0483 (0.0116) 0.0568 (0.0125) 0.0590 (0.0124) 0.0634 (0.0133) 0.0708 (0.0132) 0.0853 (0.0157) 0.1000 (0.0177) 
90 0.0481 (0.0107) 0.0532 (0.0107) 0.0537 (0.0112) 0.0586 (0.0115) 0.0685 (0.0130) 0.0804 (0.0142) 0.0949 (0.0152) 
*PELD = Pediatric end-stage liver disease model 
^ Liver transplantation 
 
Table 6. Cumulative incidences of posttransplant 5-year mortality and retransplantation accounted for waiting time by listing PELD score (standard errors are in 
the parentheses) 
 
Posttransplant  death by PELD 
< 0 0 to 10 11 to 20 > 20 
LT^ waiting time ( days)     
3 0.1060 (0.1011) 0.1219 (0.1255) 0.1551 (0.0621) 0.1538 (0.0625) 
30 0.0739 (0.3160) 0.0990 (0.0288) 0.1519 (0.0481) 0.1519 (0.0481) 
60 0.0435 (0.0188) 0.0916 (0.0357) 0.0946 (0.0267) 0.0946 (0.0267) 
90 0.0488 (0.0168) 0.0912 (0.0244) 0.0794 (0.0274) 0.0794 (0.0274) 
 Retransplantation by PELD 
 < 0 0 to 10 11 to 20 > 20 LT^ waiting time ( days)     
3 0.0000 (0.0000) 0.0985 (0.0952) 0.0942 (0.0957) 0.0925 (0.0947) 
30 0.0992 (0.0514) 0.0952 (0.0937) 0.0898 (0.0388) 0.0993 (0.0434) 
60 0.0992 (0.0284) 0.0960 (0.0305) 0.0800 (0.0265) 0.0800 (0.0265) 
90 0.0873 (0.0255) 0.0847 (0.0246) 0.0843 (0.0292) 0.0843 (0.0292) 
*PELD = Pediatric end-stage liver disease model 
^ Liver transplantation 
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Figure 9 illustrates the estimated cumulative incidences of posttransplant mortality and 
retransplantation for the LT recipients who received LT within 3 and 30 days on the waiting list, 
respectively, and for those who received LT between 4 and 305 days and between 31 and 305 
days on the waiting list, respectively. The estimated univariate cumulative incidences regardless 
of the LT waiting time were also presented in Figure 9. The curve of the univariate cumulative 
incidences of posttransplant death fell in between the two curves of the conditional cumulative 
incidences of death for the recipients who received early LT and late LT, suggesting that 
posttransplant mortality is dependent on the liver transplant wait time. LT recipients who 
received early LT had a higher posttransplant mortality rate compared with those who receive LT 
late. The curves of the conditional cumulative incidences of retransplantation for the recipients 
who received early LT and late LT agreed with the curve of the univariate cumulative incidences 
of retransplantation, suggesting that the retransplantation time has a weak association with LT 
waiting time. 
Figure 10 illustrates the cumulative incidences of posttransplant mortality and 
retransplantation for the LT recipients who received LT within 60 and 90 days of listing, 
respectively, and for those who received LT between 61 and 305 days of listing and between 91 
and 305 days of listing, respectively. The cumulative incidences of posttranplant mortality were 
similar to those having the LT waiting time of 3 days and that of 30 days, which suggests that 
posttransplant mortality is associated with the LT waiting time and that the retransplantation time 
has a weak association with the LT waiting time. 
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Figure 9. Cumulative incidences of posttransplant mortality and retransplantation accounted for liver transplant 
waiting time (the top panel is for the recipients who received LT earlier or later than 3 days and the bottom panel is 
for the recipients who received LT earlier or later than 30 days 
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Figure 10. Cumulative incidences of posttransplant mortality and retransplantation accounted for liver transplant 
waiting time (the top panel is for the recipients who received LT earlier or later than 60 days and the bottom panel is 
for the recipients who received LT earlier or later than 90 days) 
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The time-varying association between the LT waiting time and the posttransplant death 
time was estimated through Equation (2.3.4).  The odds of posttransplant death were compared 
between the LT recipients who received LT earlier and those who received LT later by various 
cutoff times.  
Figure 11 illustrates the point estimates of the odds ratios of posttransplant death with 
95% confidence intervals for the LT recipients who received LT earlier vs. later using cutoff 
time points of 3, 30, 60, and 90 days. The 95% confidence intervals were obtained based on 
1,000 bootstrap samples. Figure 12 is a zoom-in of Figure 11, truncating odds ratios up to 10. 
The estimated time-varying odds ratios of posttransplant mortality for the recipients who 
received LT within 3 days versus the recipients who received LT greater than 3 days on the 
waiting list were around the value of 2 and the corresponding 95% confidence intervals included 
1. Note that because of a few number of death and retransplantation cases, estimation of odds 
ratio may not be reliable 10 years after LT. In other scenarios presented in Figure 12, the 
estimated time-varying odds ratios of posttransplant death were around the values between 1 and 
2 with the 95% confidence intervals including 1. These results suggest that the posttransplant 
survival time is positively associated with the LT waiting time, that is, a longer LT waiting time 
is associated with a lower probability of posttransplant mortality. 
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Figure 11. Odds ratios of posttransplant death between the recipients who received LT earlier than 3, 30, 60, and 90 
days and the recipients who received LT later than 3, 30, 60, and 90 days along with 95% confidence intervals 
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Figure 12. Odds ratios of posttransplant death between the recipients who received LT earlier than 3, 30, 60, and 90 
days and the recipients who received LT later than 3, 30, 60, and 90 days along with 95% confidence intervals (odds 
ratios are up to 10)  
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Table 7 summarizes the PELD score at the time of listing by various LT waiting times 
among the LT recipients. Comparing the deceased LT recipients who received LT within 3 days 
with those who received LT after 3 days of listing, we found that over 45% of the recipients who 
received LT within 3 days of listing had PELD score greater than 20 whereas only 15% of the 
recipients who received LT after 3 days of listing had PELD score greater than 20. Among the 
recipients receiving early LT (within 30 days or within 60 days compared to greater than 30 days 
and greater than 60 days, respectively), over 30% of the recipients had PELD score greater than 
20; among the recipients receiving late LT, only 3% of the recipients had PELD score greater 
than 20. The odds ratios of posttransplant death between the recipients who received early LT 
and late LT were greater than 1; a possible explanation is that those recipients who received early 
LT were much sicker than those who received late LT.  
 
Table 7. PELD score at the time of listing by liver transplant waiting time 
 LT^ waiting time among the deceased recipients (days) 
 ≤ 3  > 3  ≤ 30  > 30  ≤ 60  > 60  ≤ 90  > 90  
 (n=11) (n=58) (n=34) (n=35) (n=42) (n=27) (n=48) (n=21) 
PELD*  n (%)         
        < 0   2 (18.18)   11 (18.97)     4 (11.76)     9 (25.71)     5 (11.90)     8 (29.63)     7 (14.58)     6 (28.57) 
        0 - 10   3 (9.09)   29 (50.00)   11 (32.35)   19 (14.29)   15 (35.71)   15 (55.56)   17 (35.42)   13 (61.90) 
        11 - 20   6 (27.27)     9 (15.52)     6 (17.65)     6 (17.14)     9 (21.43)     3 (11.11)   10 (20.83)     2 (9.52) 
        > 20 11 (45.45)     9 (15.52)   13 (38.24)     1 (2.86)   13 (30.95)     1 (3.70)   14 (29.17)     0 (0.00) 
  
LT^ waiting time among all recipients (days) 
 ≤ 3  > 3  ≤ 30  > 30  ≤ 60  > 60  ≤ 90  > 90  
 (n=72) (n=839) (n=206) (n=605) (n=451) (n=460) (n=542) (n=369) 
PELD*  n (%)         
        < 0 11 (15.28) 297 (35.40)  77 (25.16) 231 (38.18) 130 (28.82) 178 (38.70) 161 (29.70) 147 (39.84) 
        0 - 10 10 (13.89) 301 (35.88)  67 (21.90) 244 (40.33) 123 (27.27) 188 (40.87) 156 (28.78) 155 (42.01) 
        11 - 20 12 (16.67) 152 (18.12)  59 (19.28) 105 (17.36)  88 (19.51)  76 (16.52) 108 (19.93)  56 (15.18) 
         > 20 39 (54.17)    89 (10.61) 103 (33.66)   25 (4.13) 110 (24.39)   18 (3.91) 117 (21.59)    11 (2.98) 
*PELD = Pediatric end-stage liver disease model 
^ Liver transplantation 
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We also estimated the odds ratios of posttransplant death for the LT recipients who 
received LT earlier vs. later stratified by their PELD scores at the time of listing. Figure 13 
illustrates the point estimates of these odds ratios. The results indicated that the positive 
association between LT waiting time and posttransplant survival was more pronounced among 
sicker patients (higher PELD scores at the time of listing). Note that because of small sample 
sizes, odds ratios were not estimable for all time points.  
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Figure 13. Odds ratios of posttransplant death between the recipients who received LT earlier than 3, 30, 60, and 90 
days and the recipients who received LT later than 3, 30, 60, and 90 days by listing PELD 
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4.0  DISCUSSION 
In this study, we analyzed 1,265 pediatric LT candidates with chronic liver disease who were 
younger than 12 years old when being placed on the waiting list. Methods of the univariate and 
the bivariate cumulative incidence function were used to estimate the cumulative probabilities of 
posttransplant mortality and the odds ratios of posttransplant mortality between early LT 
recipients and late LT recipients. We found that posttransplant death time is dependent on the LT 
waiting time and that retransplantation has a weak association with LT waiting time. Our 
analysis also showed that LT waiting time is positively associated with posttransplant death time, 
meaning that LT recipients with shorter wait time had higher risk of posttransplant mortality. 
There are several limitations in estimating the association between the LT waiting time 
and the posttransplant survival in our study. First, among 911 LT recipients, 761 (83.5%) were 
not retransplanted and were alive at the study cutoff date therefore were censored in the analysis. 
This high censoring rate significantly reduced the effective sample size and therefore reduced the 
estimation power. Second, we suspected that our results of shorter waiting time being associated 
with higher risk of posttransplant mortality may be due to survivor bias. We will need to further 
investigate this by extending our study period so that more LT recipients will experience the 
outcomes of interest (posttransplant death or retransplantation). Third, our analysis did not take 
into account the fact that PELD scores may vary over time. A sensitivity analysis may be needed 
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to investigate the impact of using the PELD score at the time of liver transplantation vs. using the 
PELD score at the time of being put on the waiting list.  
In conclusion, the bivariate cumulative incidence function model is suitable for studying 
the association between liver transplant waiting time and posttransplant survival having 
retransplantation as a competing risk. Although our study found that liver transplant waiting time 
is positively associated with posttransplant survival and that retransplantation has a weak 
association with LT waiting time, more work should be done to further investigate the causes 
behind these findings. 
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APPENDIX: R CODE FOR BOOTSTRAP RESAMPLES 
#################################################################################################
##Create Resample ID for Bootstrap Resample n=1000           
##output csv file:  sampleXX: xxth sample                                  
##patient ID:  recode to 1 to 1265                   
#################################################################################################
##resample index; 
rs.data=c(1:1265) 
Tx.Size=1000 
 
##resample for bootstrap; 
set.seed(123) 
Tx.Resamples=lapply(1:Tx.Size, function(i) sample(rs.data,replace=TRUE)) 
 
##convert to dataframe; 
Tx.Resamples.df = do.call("cbind", lapply(Tx.Resamples, as.data.frame)) 
Tx.Resamples.name=unlist(lapply(1:Tx.Size, function(i) paste("sample", i, sep = ""))) 
colnames(Tx.Resamples.df) = Tx.Resamples.name 
 
##save as CSV file; 
write.csv(Tx.Resamples.df, file = "LiverTxResample.csv", row.names=FALSE) 
 
 
 
 
 
#################################################################################################
##Calculate CIF table for each sample of Bootstrap Resample           
################################################################################################# 
##load LinCFK; 
source("Estimator_LinCFKcondi.R") 
 
##load LiverTx dataset; 
LiverTx.Data = read.csv("LiverTxRecode.csv",header=TRUE, na.string = "NA", fill = TRUE, sep=",") 
LiverTx.Data.dm=data.matrix(subset(LiverTx.Data, 
select=c("ptid","y1","y2","x","t","eta1","eta2"))) 
 
##load Resample patientID dataset; 
LiverTx.ReSample= read.csv("LiverTxReSample.csv",header=TRUE, na.string = "NA", fill = TRUE, 
sep=",") 
 
##CIFs for each sample; 
for (i in 1:1000) { 
    ##get resample column name 
    TxPID = paste("sample", i, sep = "") 
    Tx.pt.dm = data.matrix(subset(LiverTx.ReSample,select=c(TxPID))) 
    colnames(Tx.pt.dm)= "ptid" 
    #str(Tx.pt.dm) 
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    ##retrive data by ptid index; 
    Tx.Data.dm=LiverTx.Data.dm[c(Tx.pt.dm),] 
    LiverTx.df=data.frame(Tx.Data.dm, row.names=NULL) 
 
    ##rearrange data to call estimator of  LinCFK 
    Tx.Data =subset(LiverTx.df,select=c("y1","y2","eta1","eta2")) 
    Tx_X    = LiverTx.df[,c("x")] 
    Tx_T    = LiverTx.df[,"t"] 
    Tx_ptid = LiverTx.df[,c("ptid")] 
    numpt   = length(Tx_ptid) 
 
    ##estimate CIF by using LinCFK; 
    TxOut = Est.LinCFKcondi(Tx.Data,Tx_X,Tx_T) 
    Tx.CIF = TxOut$out.CIF 
    Tx.Sx  = TxOut$out.Sx 
 
    ##get CIF Estimation of X and Y,  KM Estimation of X by patientID; 
    LinFxy1   =Tx.CIF[,1:numpt] 
    LinFxy2   =Tx.CIF[,(numpt+1):(2*numpt)] 
    LinCFxy1  =Tx.CIF[,(2*numpt+1):(3*numpt)] 
    LinCFxy2  =Tx.CIF[,(3*numpt+1):(4*numpt)] 
    IPCWFxy1  =Tx.CIF[,(4*numpt+1):(5*numpt)] 
    IPCWFxy2  =Tx.CIF[,(5*numpt+1):(6*numpt)] 
    IPCWCFxy1 =Tx.CIF[,(6*numpt+1):(7*numpt)] 
    IPCWCFxy2 =Tx.CIF[,(7*numpt+1):(8*numpt)] 
    Sx        = Tx.Sx[,1:numpt] 
    ptid.CIF.df = 
cbind(Tx_ptid,Tx.Data,Tx_X,Tx_T,LinFxy1,LinFxy2,LinCFxy1,LinCFxy2,IPCWFxy1,IPCWFxy2,IPCWCFxy1, 
IPCWCFxy2, Sx) 
 
    ##Save as CSV file; 
    write.csv(ptid.CIF.df, file = CIFpt.File.C, row.names = FALSE) 
 
    ##CIF tablesof X and Y for each cause sort by X and Y; 
    ##KM table of X; 
     
ptid.Fxy=data.matrix(ptid.CIF.df[,c("Tx_X","Tx_T","LinFxy1","LinCFxy1","IPCWFxy1","IPCWCFxy1","Li
nFxy2", "LinCFxy2", "IPCWFxy2", "IPCWCFxy2", "Sx")]) 
    ptid.Sx=data.matrix(ptid.CIF.df[,c("Tx_X","Sx")]) 
    LiverTx.Fxy=unique(ptid.Fxy[order(ptid.Fxy[,"Tx_X"],ptid.Fxy[,"Tx_T"]),]) 
    LiverTx.Sx=unique(ptid.Sx[order(ptid.Sx[,"Tx_X"]),]) 
 
    ####--Save as CSV file; 
    Fxy.File.C = paste("./LiverTxBootStrap/LiverTxCIF_S", i, ".csv", sep = "") 
    Sx.File.C  = paste("./LiverTxBootStrap/LiverTxSx_S", i, ".csv", sep = "") 
    write.csv(LiverTx.Fxy, file =Fxy.File.C, row.names = FALSE) 
    write.csv(LiverTx.Sx, file =Sx.File.C, row.names = FALSE) 
 
} 
 
 
 
 
 
#################################################################################################
##Calculate OR and 95% CI           
#################################################################################################
##load Fxy dataset; 
LiverTx.CIF= read.csv("./LiverTxBootStrap/LiverTxCIFBS.csv",header=TRUE, na.string = "NA", fill = 
TRUE, sep=",") 
 
for (k in c(1:1000)) { 
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    RSIDN = paste("RS", k, sep = "") 
    LiverTx.CIF.df = subset(LiverTx.CIF, LiverTx.CIF$RSID==RSIDN, 
select=c("Tx_X","Tx_T","LinFxy1","IPCWFxy1","LinCFxy1","IPCWCFxy1","Sx","RSID")) 
 
 
    ##find Fxy for fixed timepoint of x and t; 
    for (x in c(3,30,60,90,305)) { 
 
        T.list=subset(LiverTx.CIF.df, LiverTx.CIF.df$Tx_X <= x, select=c("Tx_T")) 
        Tx_T=unique(sort(T.list[,1])) 
        T.num=length(Tx_T) 
        Tx_X=c(rep(x,T.num)) 
        m.TX=cbind(Tx_X,Tx_T) 
 
        Tx.X = subset(LiverTx.CIF.df, LiverTx.CIF.df$Tx_X==x, select=c("Tx_X","Tx_T","IPCWCFxy1", 
"IPCWFxy1","Sx")) 
        Sx.L=min(Tx.X[,"Sx"]) 
 
        CIF.TX=merge(Tx.X, m.TX, by = "Tx_T", all = TRUE, sort = TRUE, suffixes = c(".X",".L")) 
 
        for(i in 1:T.num ) { 
           if (is.na(CIF.TX[i,"IPCWFxy1"])) {  
  CIF.TX[i,"Sx"]=Sx.L 
                x.L=CIF.TX[i,"Tx_X.L"]  
                t.L=CIF.TX[i,"Tx_T"] 
                CIF.TX.L.df= subset(LiverTx.CIF.df, LiverTx.CIF.df$Tx_X <= x.L & 
LiverTx.CIF.df$Tx_T <= t.L, select=c("Tx_X","Tx_T","IPCWFxy1"))   
                Fxy1.L=max(CIF.TX.L.df$IPCWFxy1, na.rm = TRUE) 
                CIF.TX[i,"IPCWFxy1"]=Fxy1.L 
            } 
        } 
       Yu.CIF.TX= paste("./LiverTxCIFORBootS/LiverTxCIFYuBS/LiverTxCIF_Death_x", x, "_S", 
k,".csv", sep = "") 
       write.csv(CIF.TX, file=Yu.CIF.TX, row.names = FALSE) 
    } 
 
    ##merge dataset and calculate Fxy when no timepoint matched; 
    tm=305 
    TMFile=paste("./LiverTxCIFORBootS/LiverTxCIFYuBS/LiverTxCIF_Death_x305","_S", k,".csv", sep = 
"") 
    LiverTx.CIF.TM= read.csv(TMFile,header=TRUE, na.string = "NA", fill = TRUE, sep=",") 
    Tx.M = subset(LiverTx.CIF.TM, select=c("Tx_X.L","Tx_T","IPCWFxy1","Sx")) 
 
 
    for (tx in c(3,30,60,90)){ 
 
        tx.File= paste("./LiverTxCIFORBootS/LiverTxCIFYuBS/LiverTxCIF_Death_x", tx, 
"_S",k,".csv", sep = "") 
        LiverTx.CIF.TX= read.csv(tx.File,header=TRUE, na.string = "NA", fill = TRUE, sep=",") 
        Tx.X = subset(LiverTx.CIF.TX, select=c("Tx_X.L","Tx_T","IPCWFxy1","Sx")) 
 
        CIF.Fix=merge(Tx.X, Tx.M, by = "Tx_T", all = TRUE, sort = TRUE, suffixes = c(".X",".M")) 
 
        numrow = length(CIF.Fix$Tx_T) 
        km = min(which(CIF.Fix$IPCWFxy1.M >0)) 
        km.IPCW.CIF = CIF.Fix[km,"IPCWFxy1.M"] 
        km.Sx.M = CIF.Fix[km,"Sx.M"] 
        km.M  = CIF.Fix[km,"Tx_X.M"] 
        kx = min(which(CIF.Fix$IPCWFxy1.X >0)) 
        kx.IPCW.CIF = CIF.Fix[kx,"IPCWFxy1.X"] 
        kx.X  = CIF.Fix[kx,"Tx_X.X"] 
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        kx.Sx.X = CIF.Fix[kx,"Sx.X"] 
 
        ##set CIF for each time point; 
        for ( j in 1:numrow){  
     if ( (j < km) & is.na(CIF.Fix[j,"IPCWFxy1.M"])) {     
                CIF.Fix[j,"IPCWFxy1.M"]=0 
            } 
            if (j > km) { 
               jm.IPCW.CIF=CIF.Fix[j,"IPCWFxy1.M"] 
 
               if (is.na(jm.IPCW.CIF)) { 
                   CIF.Fix[j,"IPCWFxy1.M"]=km.IPCW.CIF 
               } 
               else { 
                   km.IPCW.CIF=jm.IPCW.CIF 
               } 
            } 
 
            CIF.Fix[j,"Sx.M"]=km.Sx.M 
 
     if ( (j < kx) & is.na(CIF.Fix[j,"IPCWFxy1.X"])) {     
               CIF.Fix[j,"IPCWFxy1.X"]=0 
            } 
     if (j > kx)  { 
               jx.IPCW.CIF=CIF.Fix[j,"IPCWFxy1.X"] 
 
               if (is.na(jx.IPCW.CIF)) { 
                  CIF.Fix[j,"IPCWFxy1.X"]=kx.IPCW.CIF 
               } 
               else { 
                  kx.IPCW.CIF=jx.IPCW.CIF 
               } 
            } 
            CIF.Fix[j,"Sx.X"]=kx.Sx.X 
        } 
 
        ##joint CIF; 
        CIF.OR = CIF.Fix[!(is.na(CIF.Fix$Tx_T)),] 
        row.names(CIF.OR)=c(1:length(CIF.OR[["Tx_T"]])) 
        F.MX = CIF.OR$Sx.X[1] - CIF.OR$Sx.M[1] 
 
        ##Conditional CIF for <=x 
        CIF.OR$IPCWCFxy1.X=CIF.OR$IPCWFxy1.X/(1-CIF.OR$Sx.X) 
 
        ##Conditional CIF for between x and M 
        CIF.OR$IPCWCFxy1.XM=ifelse((CIF.OR$Sx.X - CIF.OR$Sx.M) > 0,(CIF.OR$IPCWFxy1.M - 
CIF.OR$IPCWFxy1.X)/F.MX, NA) 
        CIF.OR$IPCWCFxy1.XM[CIF.OR$IPCWCFxy1.XM < 0 ] = 0 
 
        ##Odds Ratio 
        CIF.OR$IPCW_OR = round(CIF.OR$IPCWCFxy1.X * (1-CIF.OR$IPCWCFxy1.XM )/ 
CIF.OR$IPCWCFxy1.XM*(1- CIF.OR$IPCWCFxy1.X),4) 
        CIF.OR$IPCW_OR[!(is.finite(CIF.OR$IPCW_OR)) | CIF.OR$IPCW_OR <= 0] = NA 
 
 
       Tx.OR.File.C = paste("./LiverTxCIFORBootS/BSYu_LiverTxOR_M", tm, "_x", tx, "_S",k,".csv", 
sep = "") 
       write.csv(CIF.OR, file = Tx.OR.File.C, row.names = FALSE) 
 
   } 
} 
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